M.Á. Climent
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
-
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Testicular diseases and treatments
Papers in
- Co-authors
- Yves Fradet (4 shared papers)Winald R. Gerritsen (3 shared papers)Toni K. Choueiri (3 shared papers)Andrea Necchi (4 shared papers)Dean F. Bajorin (4 shared papers)Daniel P. Petrylak (4 shared papers)Cora N. Sternberg (3 shared papers)Howard Gurney (3 shared papers)
- Journals
- Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)World Neurosurgery (1 paper)ESMO Open (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- SpainUnited StatesSouth Korea
In The Last Decade
M.Á. Climent
10 papers receiving 374 citations
M.Á. Climent's Hit Papers
Peers
Comparison fields: 5 of 36
- Oncology 244
- Surgery 264
- Pulmonary and Respiratory Medicine 92
- Urology 11
- Cancer Research 23
Countries citing papers authored by M.Á. Climent
This map shows the geographic impact of M.Á. Climent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.Á. Climent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.Á. Climent more than expected).
Fields of papers citing papers by M.Á. Climent
This network shows the impact of papers produced by M.Á. Climent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.Á. Climent. The network helps show where M.Á. Climent may publish in the future.
Co-authors
The 25 scholars most cited alongside M.Á. Climent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up Hit paper breakdown → | 2019 | 306 |
| 2 | 1993 | 33 | |
| 3 | 2004 | 23 | |
| 4 | 2020 | 5 | |
| 5 | 2006 | 3 | |
| 6 | 2017 | 3 | |
| 7 | 2018 | 2 | |
| 8 | 2006 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2012 | 1 | |
| 11 | 2024 | 0 |
About M.Á. Climent
M.Á. Climent is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Neurology, having authored 11 papers that have together received 378 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Urinary and Genital Oncology Studies (3 papers), Testicular diseases and treatments (2 papers), Esophageal Cancer Research and Treatment (2 papers), Sarcoma Diagnosis and Treatment (2 papers), Colorectal Cancer Surgical Treatments (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Oncology (244 citations), Surgery (264 citations), Pulmonary and Respiratory Medicine (92 citations), Urology (11 citations) and Cancer Research (23 citations). M.Á. Climent has collaborated with scholars based in Spain, United States and South Korea. Frequent co-authors include Yves Fradet, Winald R. Gerritsen, Toni K. Choueiri, Andrea Necchi, Dean F. Bajorin, Daniel P. Petrylak, Cora N. Sternberg, Howard Gurney, Joaquim Bellmunt and Rodolfo F. Perini. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, World Neurosurgery, ESMO Open and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.